#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine leiomyosarcoma Pancreatic carcinoma metastatic Thrombotic microangiopathy Anaemia Nodal marginal zone B-cell lymphoma Guillain-Barre syndrome Acute graft versus host disease Non-small cell lung cancer B-cell small lymphocytic lymphoma Retinoblastoma Salivary gland cancer Congenital pseudarthrosis Osteosarcoma metastatic Arginase deficiency Growth hormone deficiency More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria – Life with Disease Haemophilia A without inhibitors – Life with Disease Pulmonary sarcoidosis – Trials in Disease Andersen-Tawil syndrome – Treatment Rosai-Dorfman syndrome – Basic Information Medulloblastoma – Basic Information Fabry’s disease – Treatment Focal segmental glomerulosclerosis – Diagnostics Idiopathic pulmonary fibrosis – Life with Disease Cystic fibrosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cholesterol Sapropterin Dihydrochloride Palbociclib ADCE-D01 IDROXIOLEIC ACID Rezafungin Acetate Nemtabrutinib Ampreloxetine Tegoprubart Disitamab Vedotin Aup1602-C ARFOLITIXORIN SIPAVIBART Dopamine Hydrochloride Tinlarebant ZODASIRAN Alx148 Zalunfiban Remimazolam Heparin Sodium More therapies…

    Learn about Your Condition

    Oral neoplasm Colitis ulcerative Subdural haematoma Hypoaesthesia Malignant mast cell neoplasm Vesicoureteric reflux Skin disorder Growth hormone deficiency Deafness Systemic candida Infective uveitis Migraine Agitation Complicated appendicitis Coeliac disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness and Safety of Tocilizumab and Adalimumab for Patients with Severe Uveitis in Behçet’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Behcet’s syndrome
    • Uveitis
    Investigated Drugs:
    • Adalimumab
    • Tocilizumab
    France

  • Study on the Safety and Effects of ION582 for Patients with Angelman Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Angelman’s syndrome
    Investigated Drugs:
    • 2′-O-(2-Methoxyethyl) Modified Antisense Oligonucleotide Targeting Ube3A Antisense Transcript Rna
    France Italy

  • Study on Treatment Strategies for Children and Adolescents with Juvenile Idiopathic Arthritis Using Methotrexate and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Etanercept
    • Adalimumab
    • Golimumab
    Norway

  • Study of Combined Imaging with Hyperpolarized [1-13C]Pyruvate and Fludeoxyglucose (18F) for Cancer Detection in Patients with Breast Cancer, Neuroendocrine Tumors, Lymphomas, or Sarcomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma metastatic
    • Neuroendocrine tumour
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Pyruvic Acid
    • Fludeoxyglucose (18F)
    Denmark

  • Study on Stopping Omalizumab in Patients with Well-Controlled Severe Allergic Asthma After 3 Years of Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Omalizumab
    France

  • Study on Long-Term Safety of Pelabresib for Patients with Myelofibrosis or Essential Thrombocythemia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myeloproliferative neoplasm
    • Myelofibrosis
    Investigated Drugs:
    • 2-((4S)-6-(4-Chlorophenyl)-1-Methyl-4H-Benzo[C]Isoxazolo[4,5-E]Azepin-4-Yl)Acetamide Monohydrate
    Belgium Italy The Netherlands
Previous Page
1 … 353 354 355 356 357 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!